Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1181-1187

  Fang, Xin Mei ^a   Liu, Bin ^a   Liu, Ya Bin ^b   Wang, Jun Jie ^a   Wen, Jin Kun ^a   Li, Bing Hui ^b   Han, Mei ^a  

^a Institute of Basic Medicine   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Acetylbritannilactone; Antigrowth; Cell cycle; HT 29 cells; Kr ppel like factor 4; Mechanism; p21WAF1 Cip1

Indexed keywords

ACETYLBRITANNILACTONE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 4; CYCLIN E; KRUPPEL LIKE FACTOR 4; PROTEIN P21; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL GROWTH PROCESSES; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LACTONES; MICE; RATS; UP-REGULATION;

EID: 80053166476     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1411     Document Type: Article

References (36)

1. Cubas R, Li M, Chen C and Yao Q: Colorectal cancer: new advances in immunotherapy. Cancer Biol Ther 6: 11-17, 2007. (Pubitemid 46294169)
2. Fernandez-Majada V, Aguilera C, Villanueva A, et al: Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci USA 104: 276-281, 2007. (Pubitemid 46068022)
3. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
4. Liu B, Han M and Wen JK: Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-{kappa}B activation. J Pharmacol Exp Ther 324: 292-298, 2008. (Pubitemid 350294152)
5. Liu YP, Wen JK, Zheng B, Zhang DQ and Han M: Acetyl-britannilactone suppresses lipopolysaccharide-induced vascular smooth muscle cell inflammatory response. Eur J Pharmacol 577: 28-34, 2007. (Pubitemid 47632521)
6. Bai N, Lai CS, He K, et al: Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell lines. J Nat Prod 69: 531-535, 2006. (Pubitemid 43798096)
7. Rafi MM, Bai NS, Chi Tang H, et al: A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylation. Anticancer Res 25: 313-318, 2005. (Pubitemid 40470125)
8. Park EJ and Kim J: Cytotoxic sesquiterpene lactones from Inula britannica. Planta Med 64: 752-754, 1998. (Pubitemid 29021577)
9. Han M, Wen JK, Zheng B and Zhang DQ: Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci 75: 675-684, 2004. (Pubitemid 38686699)
10. Voutsadakis IA: Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. J Cell Mol Med 11: 252-285, 2007.
11. Liu B, Han M, Sun RH, et al: ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation. Breast Cancer Res 12: R9, 2010.
12. Shields JM, Christy RJ and Yang VW: Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 271: 20009-20017, 1996.
13. Wei D, Gong W, Kanai M, et al: Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65: 2746-2754, 2005. (Pubitemid 40490076)
14. Katz JP, Perreault N, Goldstein BG, et al: Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128: 935-945, 2005. (Pubitemid 40523545)
15. Wang C, Han M, Zhao XM and Wen JK: Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem 144: 313-321, 2008.
16. Yang Y, Goldstein BG, Chao HH and Katz JP: KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 4: 1216-1221, 2005.
17. Zheng B, Han M, Bernier M, et al: Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J Biol Chem 284: 22773-22785, 2009.
18. Dang DT, Chen X, Feng J, Torbenson M, Dang LH and Yang VW: Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenicity. Oncogene 22: 3424-3430, 2003. (Pubitemid 36713740)
19. Zhang W, Chen X, Kato Y, et al: Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 26: 2055-2064, 2006. (Pubitemid 43346910)
20. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE and Yang VW: Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23: 395-402, 2004. (Pubitemid 38174993)
21. Rowland BD, Bernards R and Peeper DS: The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7: 1074-1082, 2005.
22. Dong LH, Wen JK, Liu G, et al: Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia. Arterioscler Thromb Vasc Biol 30: 683-691, 2010.
23. Mitchell C, Yacoub A, Hamed H, et al: Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. Cancer Biol Ther 10: 903-917, 2010.
24. Zheng B, Han M and Wen JK: Role of Kruppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells. IUBMB Life 62: 132-139, 2010.
25. Ghaleb AM, Aggarwal G, Bialkowska AB, Nandan MO and Yang VW: Notch inhibits expression of the Kruppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol Cancer Res 6: 1920-1927, 2008.
26. Wei D, Kanai M, Jia Z, Le X and Xie K: Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 68: 4631-4639, 2008.
27. Guo Y, Costa R, Ramsey H, et al: The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci USA 99: 3663-3667, 2002. (Pubitemid 34252163)
28. Chen X, Johns DC, Geiman DE, et al: Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 276: 30423-30428, 2001.
29. Yoon HS, Chen X and Yang VW: Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 278: 2101-2105, 2003. (Pubitemid 36801273)
30. Chen X, Whitney EM, Gao SY and Yang VW: Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol 326: 665-677, 2003. (Pubitemid 36279310)
31. Yoon HS and Yang VW: Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 279: 5035-5041, 2004. (Pubitemid 38199100)
32. Chen ZY, Wang X, Zhou Y, Offner G and Tseng CC: Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res 65: 10394-10400, 2005. (Pubitemid 41743733)
33. Nakamura T, Tsuchiya K and Watanabe M: Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision. J Gastroenterol 42: 705-710, 2007. (Pubitemid 47456757)
34. Di Valentin E, Crahay C, Garbacki N, et al: New asthma biomarkers: lessons from murine models of acute and chronic asthma. Am J Physiol Lung Cell Mol Physiol 296: L185-L197, 2009.
35. Wei D, Kanai M, Huang S and Xie K: Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27: 23-31, 2006. (Pubitemid 43032979)
36. Zhang W, Geiman DE, Shields JM, et al: The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398, 2000. (Pubitemid 30414796)